Adherence to quality indicators low in chronic myeloid leukemia

by Elana Gotkine HealthDay ReporterFor newly diagnosed chronic-phase chronic myeloid leukemia (CML) patients, adherence to guideline-based quality indicators is low, according to a study published onl

Updated on: December 28,2023

Adherence to quality indicators low in chronic myeloid leukemia

by Elana Gotkine HealthDay ReporterFor newly diagnosed chronic-phase chronic myeloid leukemia (CML) patients, adherence to guideline-based quality indicators is low, according to a study published onl

Updated on:December 28,2023

Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainBlack women treated with neoadjuvant endocrine therapy for breast cancer were more likely to benefit than white women

Updated on: January 13,2024

Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainBlack women treated with neoadjuvant endocrine therapy for breast cancer were more likely to benefit than white women

Updated on:January 13,2024

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel

Updated on: January 11,2024

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel

Updated on:January 11,2024

Study: More paid sick leave results in more cancer screenings

by Tulane UniversityCredit: Unsplash/CC0 Public DomainFor most Americans, the two major obstacles to proper medical care are time and money. And while insurance can sometimes reduce health care c

Updated on: February 18,2024

Study: More paid sick leave results in more cancer screenings

by Tulane UniversityCredit: Unsplash/CC0 Public DomainFor most Americans, the two major obstacles to proper medical care are time and money. And while insurance can sometimes reduce health care c

Updated on:February 18,2024

Researchers discover new tool for improving pancreatic cancer care

by Champalimaud Centre for the UnknownCredit: Unsplash/CC0 Public DomainThe statistics for pancreatic cancer are sobering. With a five-year survival rate of only 9%, incidence of the most common type,

Updated on: February 23,2024

Researchers discover new tool for improving pancreatic cancer care

by Champalimaud Centre for the UnknownCredit: Unsplash/CC0 Public DomainThe statistics for pancreatic cancer are sobering. With a five-year survival rate of only 9%, incidence of the most common type,

Updated on:February 23,2024

Metastasis enablers: Findings could unlock new ovarian cancer treatments

by Tom Ziemer,University of Wisconsin-MadisonBiomedical engineering professor Pam Kreeger and other lab members have teased out how one type of immune cells helps cancer cells attach in the peri

Updated on: April 01,2024

Metastasis enablers: Findings could unlock new ovarian cancer treatments

by Tom Ziemer,University of Wisconsin-MadisonBiomedical engineering professor Pam Kreeger and other lab members have teased out how one type of immune cells helps cancer cells attach in the peri

Updated on:April 01,2024

Deadly liver cancer rewires cell metabolism to grow, study finds

by Krishna Ramanujan,Cornell UniversityGraphical abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101699A deadly liver cancer that mainly affects children and y

Updated on: September 07,2024

Deadly liver cancer rewires cell metabolism to grow, study finds

by Krishna Ramanujan,Cornell UniversityGraphical abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101699A deadly liver cancer that mainly affects children and y

Updated on:September 07,2024

Shape-shifting fat cells fuel breast cancer growth

Updated on: January 15,2024

Shape-shifting fat cells fuel breast cancer growth

Updated on:January 15,2024

Osimertinib with savolitinib demonstrates stronger efficacy than osimertinib alone in some patients

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response

Updated on: September 27,2024

Osimertinib with savolitinib demonstrates stronger efficacy than osimertinib alone in some patients

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response

Updated on:September 27,2024

Oncogenic driver FGFR3-TACC3 requires 5 coiled-coil heptads for activation and disulfide bonds for stability

by Impact Journals LLCFGFR3-TACC3 fusion proteins. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28359FGFR3-TACC3 represents an oncogenic fusion protein frequently identified in gliobl

Updated on: January 30,2024

Oncogenic driver FGFR3-TACC3 requires 5 coiled-coil heptads for activation and disulfide bonds for stability

by Impact Journals LLCFGFR3-TACC3 fusion proteins. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28359FGFR3-TACC3 represents an oncogenic fusion protein frequently identified in gliobl

Updated on:January 30,2024

Smartphone app monitors cancer patients recovery

by University of Pittsburgh Schools of the Health SciencesCredit: CC0 Public DomainCancer patients receiving chemotherapy can be remotely monitored using their smartphone sensors and an algorithm

Updated on: April 09,2024

Smartphone app monitors cancer patients recovery

by University of Pittsburgh Schools of the Health SciencesCredit: CC0 Public DomainCancer patients receiving chemotherapy can be remotely monitored using their smartphone sensors and an algorithm

Updated on:April 09,2024

New compound advances into Phase 1 trial for pancreatic cancer

by Sanford Burnham Prebys Medical Discovery InstituteErkki Ruoslahti, M.D., Ph.D., distinguished professor at SBP and founder, president and CEO of DrugCendR. Credit: John GestaldoA compound disc

Updated on: April 09,2024

New compound advances into Phase 1 trial for pancreatic cancer

by Sanford Burnham Prebys Medical Discovery InstituteErkki Ruoslahti, M.D., Ph.D., distinguished professor at SBP and founder, president and CEO of DrugCendR. Credit: John GestaldoA compound disc

Updated on:April 09,2024